Related Experiment Video
Updated: Jun 13, 2026

Targeted Muscle Reinnervation: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain
Published on: March 8, 2024
Multiple sclerosis-related central pain disorders
Turo J Nurmikko1, Sameer Gupta, Kate Maclver
1Neuroscience Research Unit, Clinical Sciences Centre, Lower Lane, Liverpool, L9 7AL, UK. tjn@liverpool.ac.uk
Abstract:
Central neuropathic pain is common in multiple sclerosis (MS), and its prevalence increases with physical disability. Sufficient evidence links dysesthetic pain, trigeminal neuralgia, Lhermitte's sign, and painful tonics spasms to plaque formation in the spinal cord and brain, whereas the association with headache and back pain remains unclear. Management varies according to the pain in question. For dysesthetic pain, drugs in use for neuropathic pain in general are recommended as first-line treatment, and emerging evidence suggests some benefit from cannabinoids and levetiracetam. Because of unique characteristics of MS-related trigeminal neuralgia, ganglion and root level neuroablative procedures are worth considering before microvascular decompression. Overall, the lack of controlled clinical trials, together with our limited understanding of the pathophysiological mechanisms involved, form a hindrance to a systematic and rational management of MS-related pain.
Related Concept Videos
Multiple Sclerosis l: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Nociception
Analgesia and Pain Management
Degenerative Disc Disease ll: Pathophysiology
Peripheral Artery Disease V: Postoperative Nursing Management

